TECKRO, INC.

Profile

Company Names

TECKRO, INC.

Addresses

THE BANK BUILDING, 63, O-CONNELL STREET, LIMERICK, L2 V94 XT62

Phone Numbers

353 61 313 610

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$62,345,980.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2021-11-08 
$24,999,989.00 
$24,999,989.00 
$0.00 
Equity 
4
2018-12-21 
$21,099,994.00 
$24,999,999.00 
$3,900,005.00 
Equity 
3
2017-07-31 
$9,999,999.00 
$9,999,999.00 
$0.00 
Equity 
2
2017-05-10 
$246,000.00 
$1,340,090.00 
$1,094,090.00 
 
1
2016-08-01 
$5,999,998.00 
$6,000,000.00 
$2.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SHAAN 
 
GHANDI 
DIRECTOR
TECKRO, INC.
PETER 
 
GRAY 
DIRECTOR
ALTUS REALTY INCOME FUND, LLC   |  TECKRO, INC.   |  ALTUS REALTY INCOME FUND II, LLC   |  ZIP CO LTD   |  GOLF VIEW APARTMENTS LLC
GARY 
 
HUGHES 
EXECUTIVE OFFICER, DIRECTOR
TECKRO, INC.   |  EMMETSBURG BANK SHARES, INC.
NIGEL 
 
HUGHES 
EXECUTIVE OFFICER, DIRECTOR
TECKRO, INC.
CRAIG 
 
LIPSET 
DIRECTOR
EMPIRICAN GROUP INC.   |  CIRCUIT CLINICAL SOLUTIONS INC.   |  TECKRO, INC.   |  MEDVECTOR CORP
IAN 
 
RATCLIFFE 
DIRECTOR
GLOBAL CELL SOLUTIONS INC   |  STEMGENT INC   |  STEMGENT, INC.   |  ENZYMATICS INC   |  FRESHAIR SENSOR LLC   |  MITRA RXDX, INC.   |  AGILIS BIOTHERAPEUTICS, INC.   |  AVITIDE, INC.   |  ACESSA HEALTH INC.   |  SANDS CAPITAL PRIVATE GROWTH FUND III, L.P.   |  NANOVIEW DIAGNOSTICS INC.   |  SANDS CAPITAL VENTURES FUND-SLK, L.P.   |  TECKRO, INC.   |  SANDS CAPITAL PRIVATE GROWTH FUND III-DC, L.P.   |  SCM-S72-1, LLC   |  NANOVIEW BIOSCIENCES, INC.   |  VITARA BIOMEDICAL, INC.   |  SANDS CAPITAL GLOBAL VENTURE FUND III, L.P.
JOHN 
 
SEXTON 
EXECUTIVE OFFICER
WEST END BUTTERFIELD HOLDINGS LLC   |  TECKRO, INC.   |  GURNEE MEDICAL LLC
JACEK 
 
SKRZYPIEC 
EXECUTIVE OFFICER
TECKRO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-11-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-08 
2019-01-03
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-21 
2017-08-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-31 
2017-08-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2017-05-10 
2016-08-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#